Saxenda Injectable Pens (Liraglutide) 6 Mg/mL

US $556.00

Pack with 5 pre-filled syringes x 3ml each – 6 mg/ml
Saxenda 6 mg
Saxenda Injectable Pens (Liraglutide) 6 Mg/mL US $556.00
Prescription Required

Fast & Secure shipping on all orders

  • Quality & Safety Guarantee
  • Typically arrives within 3 – 5 Business days
Guaranteed Safe Checkout

About Saxenda Injectable Pens

(See the Original Document Here)

Type of medication
Non-insulin injection taken subcutaneously.
Assist in
Prescription medication.
Treatment of
Used for
Adults – YES;  Children – No.
Medicine family
Man-made, which is a form of intermediate-acting insulin.
Once weekly as prescribed.

What is Type 2 Diabetes? When a person has type 2 diabetes, body cells become resistant to insulin. As a result, your body makes more insulin to get cells to respond. This imbalance in your blood sugar may lead to type 2 diabetes. High blood sugar can cause serious health problems causing amputation or affecting your heart, vision, and kidneys.

What is Type 1 diabetes? Type 1 diabetes is an immune system disorder in which the body cannot make insulin or the body produces insulin in a tiny amount.

Saxenda Injectable Pens contains liraglutide, an analog of human insulin. This type of insulin uses DNA technology in Saccharomyces cerevisiae. GLP-1 acts as a GLP-1 receptor agonist. The peptide precursor of liraglutide, produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae, is engineered to be 97% homologous to native human GLP-1. It is a clear, colorless solution. Each 1 mL of SAXENDA solution contains 6 mg of liraglutide. Each pre-filled pen of 3 mL solution contains a total of 18 mg liraglutide (free-base, anhydrous). Liraglutide is a long-acting Glucagon-like Peptide-1 (GLP-1) receptor agonist. Liraglutide inside Saxenda Injectable Pens is a long-acting GLP-1 receptor agonist. It will release more insulin in the blood as the blood glucose increases, and insulin release decreases as the demand for insulin in the body reduces.

Glucagon-like peptide-1 (GLP-1) receptor works in three ways to control blood glucose.

  • It helps the body produce more insulin.
  • It helps slow down the liver’s release of sugar into the bloodstream.
  • It slows the rate at which food leaves your stomach and passes into the intestine.

Warning while using Saxenda Injectable Pens

For Saxenda Injectable Pens 6 Mg/m, some risks associated with this type of medicine are listed below:

  • Risk of Thyroid C-Cell Tumours
  • Breast neoplasms
  • Cardiovascular
  • Endocrine and Metabolism
  • Hypoglycemia
  • Hepatic/Biliary/Pancreatic
  • Acute Gallbladder Disease
  • Immune
  • Hypersensitivity Reactions
  • Psychiatric
  • Suicidal Behavior and Ideation

Other precautions while using Saxenda Injectable Pens

  • Pregnant Women – Do not use SAXENDA during pregnancy.
  • Breastfeeding – Women who are nursing.
  • Should discontinue SAXENDA treatment.
  • Pediatrics – Can be used for children between 12 and 18 years.
  • Geriatrics – Patients above 65 years may experience gastrointestinal side effects.
  • Cardiovascular – SAXENDA should be used cautiously in patients with recent myocardial infarction, unstable angina, and congestive heart failure.
  • Hepatic Insufficiency – SAXENDA is not recommended.
  • Renal Insufficiency – Use caution when initiating or escalating doses of Saxenda.

Gastrointestinal Disorders may include:

  • Nausea
  • Diarrhea
  • Constipation
  • Vomiting
  • Dyspepsia
  • Abdominal Pain
  • Abdominal Pain Upper
  • Abdominal distension
  • Eructation
  • Flatulence
  • Gastroesophageal Reflux Disease
  • Dry Mouth
  • Gastritis

Symptoms of Hypoglycaemia may include:

  • dizziness or lightheartedness
  • blurred vision
  • anxiety, irritability, or mood changes
  • sweating
  • slurred speech
  • hunger
  • confusion or drowsiness
  • shakiness
  • weakness
  • headache
  • fast heartbeat
  • feeling jittery

Saxenda Injectable Pens

Saxenda Injectable Pens

What is the dosage of Saxenda Injectable Pens

  • Do not use Saxenda and Victoza together, as they have a common ingredient.
  • SAXENDA and Victoza are not a substitute for each other.
  • Do not take SAXENDA with another insulin.
  • For Patients with Type 2 Diabetes Mellitus: Do not combine SAXENDA with another GLP-1 receptor agonist.
  • SAXENDA is not a substitute for insulin.
  • If you discontinue SAXENDA in patients with type 2, you may observe an increase in blood glucose.

In adults with an initial BMI of 27 kg/m2 or greater, the recommended daily maintenance dose is 3.0 mg/day. Daily doses higher than 3.0 mg are not recommended.

How to store Saxenda Injectable Pens?

Store Saxenda Injectable Pens in a refrigerator (2ºC to 8ºC). Do not store in the freezer or directly adjacent to the refrigerator cooling element. Do not freeze SAXENDA®, and do not use SAXENDA® if it is ever frozen. After initial use of the Saxenda Injectable Pens, the product can be stored for 30 days at room temperature (not above 30°C) or in a refrigerator (2°C to 8°C).

Unused: Store in a refrigerator (2ºC to 8ºC). Do not freeze. Discard Saxenda Injectable Pens if frozen.

Used: Until expiry or a maximum of 30 days at room temperature (not above 30°C) or in a refrigerator (2°C to 8°C).